Cargando…
Oestrogen receptor expression distinguishes non-ossifying fibroma from other giant cell containing bone tumours
Non-ossifying fibroma (NOF) and central giant cell granuloma (CGCG) are both benign tumours of bone with overlapping morphology and similar mutations in the RAS/MAPK pathway. However, NOF is located in the long bones with regression after puberty in contrast to CGCG which is located in the jaw bones...
Autores principales: | Cleven, Arjen H. G., Schreuder, Willem H., Groen, Eline, de Lange, Jan, Briaire-de Bruijn, Inge H., Bovée, Judith V. M. G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534796/ https://www.ncbi.nlm.nih.gov/pubmed/35612673 http://dx.doi.org/10.1007/s00428-022-03341-4 |
Ejemplares similares
-
Giant cemento-ossifying fibroma of the mandible
por: Naik, Raghavendra Mahadev, et al.
Publicado: (2014) -
Molecular findings in maxillofacial bone tumours and its diagnostic value
por: Cleven, Arjen H.G., et al.
Publicado: (2019) -
Utility of FOS as diagnostic marker for osteoid osteoma and osteoblastoma
por: Lam, Suk Wai, et al.
Publicado: (2019) -
Juvenile aggressive ossifying fibroma
por: Chandra, H. Jagadish, et al.
Publicado: (2022) -
Ossifying fibroma of the sella turcica.
por: Sharma, V., et al.
Publicado: (1992)